Ezzo D[au] - Search Results

Year	Number of Results
2007	1
2008	1
2009	2
2013	1
2017	3
2018	1
2019	2
2020	1
2021	0

1

Treatment and managed care issues of atopic dermatitis.

Ezzo D. Ezzo D. Am J Manag Care. 2017 Jun;23(8 Suppl):S124-S131. Am J Manag Care. 2017. PMID: 28978209 Free article. Review.

2

An interprofessional experience in diabetes management for pharmacy and medical students.

Pisano M, Mazzola N, Block L, Ezzo D, Lu C, Coletti DJ. Pisano M, et al. Among authors: ezzo d. Curr Pharm Teach Learn. 2020 Apr;12(4):459-464. doi: 10.1016/j.cptl.2019.12.031. Epub 2020 Jan 17. Curr Pharm Teach Learn. 2020. PMID: 32334763

3

Dominant collagen XII mutations cause a distal myopathy.

Mohassel P, Liewluck T, Hu Y, Ezzo D, Ogata T, Saade D, Neuhaus S, Bolduc V, Zou Y, Donkervoort S, Medne L, Sumner CJ, Dyck PJB, Wierenga KJ, Tennekoon G, Finkel RS, Chen J, Winder TL, Staff NP, Foley AR, Koch M, Bönnemann CG. Mohassel P, et al. Among authors: ezzo d. Ann Clin Transl Neurol. 2019 Oct;6(10):1980-1988. doi: 10.1002/acn3.50882. Epub 2019 Sep 11. Ann Clin Transl Neurol. 2019. PMID: 31509352 Free PMC article.

4

Expanding Phenotype of De Novo Mutations in GNAO1: Four New Cases and Review of Literature.

Schorling DC, Dietel T, Evers C, Hinderhofer K, Korinthenberg R, Ezzo D, Bönnemann CG, Kirschner J. Schorling DC, et al. Among authors: ezzo d. Neuropediatrics. 2017 Oct;48(5):371-377. doi: 10.1055/s-0037-1603977. Epub 2017 Jun 19. Neuropediatrics. 2017. PMID: 28628939 Review. No abstract available.

5

New therapeutic alternatives for the management of dyslipidemia.

Cassagnol M, Ezzo D, Patel PN. Cassagnol M, et al. Among authors: ezzo d. J Pharm Pract. 2013 Dec;26(6):528-40. doi: 10.1177/0897190013507582. Epub 2013 Oct 18. J Pharm Pract. 2013. PMID: 24142496

6

HSP and deafness: Neurocristopathy caused by a novel mosaic SOX10 mutation.

Donkervoort S, Bharucha-Goebel D, Yun P, Hu Y, Mohassel P, Hoke A, Zein WM, Ezzo D, Atherton AM, Modrcin AC, Dasouki M, Foley AR, Bönnemann CG. Donkervoort S, et al. Among authors: ezzo d. Neurol Genet. 2017 May 15;3(3):e151. doi: 10.1212/NXG.0000000000000151. eCollection 2017 Jun. Neurol Genet. 2017. PMID: 28534044 Free PMC article.

7

Doripenem (doribax), a new carbapenem antibacterial agent.

Hilas O, Ezzo DC, Jodlowski TZ. Hilas O, et al. Among authors: ezzo dc. P T. 2008 Mar;33(3):134-80. P T. 2008. PMID: 19750153 Free PMC article. No abstract available.

8

Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.

Hu Y, Mohassel P, Donkervoort S, Yun P, Bolduc V, Ezzo D, Dastgir J, Marshall JL, Lek M, MacArthur DG, Foley AR, Bönnemann CG. Hu Y, et al. Among authors: ezzo d. J Neuromuscul Dis. 2019;6(4):475-483. doi: 10.3233/JND-190414. J Neuromuscul Dis. 2019. PMID: 31498126 Free PMC article.

9

Nebivolol (bystolic), a novel Beta blocker for hypertension.

Hilas O, Ezzo D. Hilas O, et al. Among authors: ezzo d. P T. 2009 Apr;34(4):188-92. P T. 2009. PMID: 19561858 Free PMC article. No abstract available.

10

Facial flushing associated with duloxetine use.

Ezzo DC, Patel PN. Ezzo DC, et al. Am J Health Syst Pharm. 2007 Mar 1;64(5):495-6. doi: 10.2146/ajhp060069. Am J Health Syst Pharm. 2007. PMID: 17322162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results